CIK 0001829802 · <br>Emerging growth company
Faeth Therapeutics, Inc.
Sign in to watch- Ticker
- FTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 512-200-2982
- Business address
- 701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
- Former names
- Sensei Biotherapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-05 | Cambrian BioPharma Inc 10% owner | Sale | −1,745 | $12.29 | $21K | 161,401 |
| 2025-12-05 | Cambrian BioPharma Inc 10% owner | Sale | −42 | $13.16 | $553 | 161,359 |
| 2025-12-05 | Peyer James 10% owner | Sale | −14,508 | $11.40 | $165K | 163,146 |
| 2025-12-05 | Peyer James 10% owner | Sale | −1,745 | $12.29 | $21K | 161,401 |
| 2025-12-05 | Peyer James 10% owner | Sale | −42 | $13.16 | $553 | 161,359 |
| 2025-12-04 | Cambrian BioPharma Inc 10% owner | Sale | −5,000 | $9.06 | $45K | 177,654 |
| 2025-12-04 | Peyer James 10% owner | Sale | −5,000 | $9.06 | $45K | 177,654 |
| 2025-05-21 | Cambrian BioPharma Inc 10% owner | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2025-05-21 | RICKS THOMAS G Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2025-05-21 | Peyer James Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2025-05-21 | Humer Kristian Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2025-05-21 | Holmen Bob Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2025-05-21 | RINGO WILLIAM R Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2025-02-19 | Celebi John PRESIDENT AND CEO | Shares withheld for taxes | −5,558 | $0.48 | $3K | 105,862 |
| 2025-02-19 | van der Horst Edward CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −2,276 | $0.48 | $1K | 59,794 |
| 2025-02-14 | Krebs Stephanie Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2025-02-14 | Craver Josiah Principal Financial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-02-14 | Celebi John PRESIDENT AND CEO | Grant or award · Stock Option (Right to Buy) | +360,000 | 360,000 | ||
| 2025-02-14 | van der Horst Edward CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +110,000 | 110,000 | ||
| 2024-12-20 | Krebs Stephanie Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 |
Page 7 of 12 · 238 trades